KRAS and MAPK1 Gene Amplification in Type II Ovarian Carcinomas

In this study, we examined the clinical significance of KRAS and MAPK1 amplification and assessed whether these amplified genes were potential therapeutic targets in type II ovarian carcinoma. Using fluorescence in situ hybridization, immunohistochemistry, and retrospectively collected clinical data...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Rahman, Mohammed Tanjimur, Nakayama, Kentaro, Rahman, Munmun, Katagiri, Hiroshi, Katagiri, Atsuko, Ishibashi, Tomoka, Ishikawa, Masako, Sato, Emi, Iida, Kouji, Nakayama, Naomi, Ishikawa, Noriyuki, Miyazaki, Kohji
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Molecular Diversity Preservation International (MDPI) 2013
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3742215/
https://ncbi.nlm.nih.gov/pubmed/23820584
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms140713748
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia